Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response

Detalles Bibliográficos
Autores: Aguirre-Ena, X. (Xabier)|||/items/2a000d9c-cb5c-4734-a32c-4fef79998c86, Fontalba, A. (A.)|||/items/25d7212e-3dfe-4699-9886-965774e9ce04, Andreu, E.J. (Enrique José)|||/items/bfb7adec-1ed3-4313-a2a7-8b026c48eba6, Odero, M.D. (Maria Dolores)|||/items/6679bbec-f7dd-480c-a44c-44d7c8493251, Larrayoz-Ilundáin, M.J. (María José)|||/items/7e29cbb9-798d-4830-bfcf-729a99e05d02, Montiel-Duarte, C. (Cristina)|||/items/ac5de69e-0748-499b-b349-2b6bac8fd249, Calasanz-Abinzano, M.J. (Maria Jose)|||/items/a1f10f5c-06ce-47eb-bfd8-91fb972d8086, Fernandez-Luna, J.L. (J.L.)|||/items/44b3d4a7-5d7b-41fb-a2ef-44ec38f0de00, Prosper-Cardoso, F. (Felipe)|||/items/3d1b0b82-06c3-4e63-8280-e903dc4dc0c1
Tipo de recurso: artículo
Fecha de publicación:2003
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/19573
Acceso en línea:https://hdl.handle.net/10171/19573
Access Level:acceso abierto
Palabra clave:Imatinib
Chronic myeloid leukemia
Bcr-Abl mutations
Drug resistance
Área de Terapia Celular
id ES_063cb81e9cbab3982fc2e7e96db73bf5
oai_identifier_str oai:dadun.unav.edu:10171/19573
network_acronym_str ES
network_name_str España
repository_id_str
spelling Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of responseAguirre-Ena, X. (Xabier)|||/items/2a000d9c-cb5c-4734-a32c-4fef79998c86Fontalba, A. (A.)|||/items/25d7212e-3dfe-4699-9886-965774e9ce04Andreu, E.J. (Enrique José)|||/items/bfb7adec-1ed3-4313-a2a7-8b026c48eba6Odero, M.D. (Maria Dolores)|||/items/6679bbec-f7dd-480c-a44c-44d7c8493251Larrayoz-Ilundáin, M.J. (María José)|||/items/7e29cbb9-798d-4830-bfcf-729a99e05d02Montiel-Duarte, C. (Cristina)|||/items/ac5de69e-0748-499b-b349-2b6bac8fd249Calasanz-Abinzano, M.J. (Maria Jose)|||/items/a1f10f5c-06ce-47eb-bfd8-91fb972d8086Fernandez-Luna, J.L. (J.L.)|||/items/44b3d4a7-5d7b-41fb-a2ef-44ec38f0de00Prosper-Cardoso, F. (Felipe)|||/items/3d1b0b82-06c3-4e63-8280-e903dc4dc0c1ImatinibChronic myeloid leukemiaBcr-Abl mutationsDrug resistanceÁrea de Terapia CelularFerrata Storti FoundationDadun. Depósito Académico Digital Universidad de Navarra20112011-11-1020032003-01-0120032003-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/19573reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/195732026-06-21T12:47:57Z
dc.title.none.fl_str_mv Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response
title Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response
spellingShingle Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response
Aguirre-Ena, X. (Xabier)|||/items/2a000d9c-cb5c-4734-a32c-4fef79998c86
Imatinib
Chronic myeloid leukemia
Bcr-Abl mutations
Drug resistance
Área de Terapia Celular
title_short Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response
title_full Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response
title_fullStr Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response
title_full_unstemmed Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response
title_sort Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response
dc.creator.none.fl_str_mv Aguirre-Ena, X. (Xabier)|||/items/2a000d9c-cb5c-4734-a32c-4fef79998c86
Fontalba, A. (A.)|||/items/25d7212e-3dfe-4699-9886-965774e9ce04
Andreu, E.J. (Enrique José)|||/items/bfb7adec-1ed3-4313-a2a7-8b026c48eba6
Odero, M.D. (Maria Dolores)|||/items/6679bbec-f7dd-480c-a44c-44d7c8493251
Larrayoz-Ilundáin, M.J. (María José)|||/items/7e29cbb9-798d-4830-bfcf-729a99e05d02
Montiel-Duarte, C. (Cristina)|||/items/ac5de69e-0748-499b-b349-2b6bac8fd249
Calasanz-Abinzano, M.J. (Maria Jose)|||/items/a1f10f5c-06ce-47eb-bfd8-91fb972d8086
Fernandez-Luna, J.L. (J.L.)|||/items/44b3d4a7-5d7b-41fb-a2ef-44ec38f0de00
Prosper-Cardoso, F. (Felipe)|||/items/3d1b0b82-06c3-4e63-8280-e903dc4dc0c1
author Aguirre-Ena, X. (Xabier)|||/items/2a000d9c-cb5c-4734-a32c-4fef79998c86
author_facet Aguirre-Ena, X. (Xabier)|||/items/2a000d9c-cb5c-4734-a32c-4fef79998c86
Fontalba, A. (A.)|||/items/25d7212e-3dfe-4699-9886-965774e9ce04
Andreu, E.J. (Enrique José)|||/items/bfb7adec-1ed3-4313-a2a7-8b026c48eba6
Odero, M.D. (Maria Dolores)|||/items/6679bbec-f7dd-480c-a44c-44d7c8493251
Larrayoz-Ilundáin, M.J. (María José)|||/items/7e29cbb9-798d-4830-bfcf-729a99e05d02
Montiel-Duarte, C. (Cristina)|||/items/ac5de69e-0748-499b-b349-2b6bac8fd249
Calasanz-Abinzano, M.J. (Maria Jose)|||/items/a1f10f5c-06ce-47eb-bfd8-91fb972d8086
Fernandez-Luna, J.L. (J.L.)|||/items/44b3d4a7-5d7b-41fb-a2ef-44ec38f0de00
Prosper-Cardoso, F. (Felipe)|||/items/3d1b0b82-06c3-4e63-8280-e903dc4dc0c1
author_role author
author2 Fontalba, A. (A.)|||/items/25d7212e-3dfe-4699-9886-965774e9ce04
Andreu, E.J. (Enrique José)|||/items/bfb7adec-1ed3-4313-a2a7-8b026c48eba6
Odero, M.D. (Maria Dolores)|||/items/6679bbec-f7dd-480c-a44c-44d7c8493251
Larrayoz-Ilundáin, M.J. (María José)|||/items/7e29cbb9-798d-4830-bfcf-729a99e05d02
Montiel-Duarte, C. (Cristina)|||/items/ac5de69e-0748-499b-b349-2b6bac8fd249
Calasanz-Abinzano, M.J. (Maria Jose)|||/items/a1f10f5c-06ce-47eb-bfd8-91fb972d8086
Fernandez-Luna, J.L. (J.L.)|||/items/44b3d4a7-5d7b-41fb-a2ef-44ec38f0de00
Prosper-Cardoso, F. (Felipe)|||/items/3d1b0b82-06c3-4e63-8280-e903dc4dc0c1
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv Imatinib
Chronic myeloid leukemia
Bcr-Abl mutations
Drug resistance
Área de Terapia Celular
topic Imatinib
Chronic myeloid leukemia
Bcr-Abl mutations
Drug resistance
Área de Terapia Celular
publishDate 2003
dc.date.none.fl_str_mv 2003
2003-01-01
2003
2003-01-01
2011
2011-11-10
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/19573
url https://hdl.handle.net/10171/19573
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Ferrata Storti Foundation
publisher.none.fl_str_mv Ferrata Storti Foundation
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869402903782883328
score 15,300719